Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.
about
Raised mammographic density: causative mechanisms and biological consequencesStromal characteristics may hold the key to mammographic density: the evidence to dateMammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapiesVision 20/20: Mammographic breast density and its clinical applicationsThe Short-Term Effect of Weight Loss Surgery on Volumetric Breast Density and Fibroglandular Volume.Automated breast segmentation of fat and water MR images using dynamic programming.Joint modelling of longitudinal and survival data: incorporating delayed entry and an assessment of model misspecificationQualitative Versus Quantitative Mammographic Breast Density Assessment: Applications for the US and AbroadArea and volumetric density estimation in processed full-field digital mammograms for risk assessment of breast cancer.Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.Breast Tissue Composition and Immunophenotype and Its Relationship with Mammographic Density in Women at High Risk of Breast Cancer.One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.Determinants of the reliability of ultrasound tomography sound speed estimates as a surrogate for volumetric breast density.Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis.Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohortSample size and power determination when limited preliminary information is availableLongitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using TamoxifenAssociation of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional studyQuantra™ should be considered a tool for two-grade scale mammographic breast density classification.Quantitative 3D breast magnetic resonance imaging fibroglandular tissue analysis and correlation with qualitative assessments: a feasibility studyMammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications.Aromatase inhibitor-induced modulation of breast density: clinical and genetic effectsCombined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations StudyAssociation of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment.Mammographic density-a review on the current understanding of its association with breast cancer.The Impact of Acquisition Dose on Quantitative Breast Density Estimation with Digital Mammography: Results from ACRIN PA 4006.Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.Breast-density measurement using photon-counting spectral mammography.The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues.A comprehensive tool for measuring mammographic density changes over time.Review of quantitative multiscale imaging of breast cancer.Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers.Prognostic value of mammographic breast density in patients with metastatic breast cancer.Finding cancer in mammograms: if you know it's there, do you know where?Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis
P2860
Q26753088-FB338DEE-BE2F-4363-93F6-92C747D9F72AQ28066162-DE55D7A8-1446-495F-9247-BAC5A00B3E0FQ28074177-71CE8417-281D-4C3B-A424-9AC9E7336A25Q28081408-0FD7555D-B63C-4A8F-8498-2A223EB8583EQ30275608-6E28405D-352E-40C2-99AE-D70E89D80A71Q30883676-22346EC5-D578-4617-AC64-945F0A8E686EQ31012975-6B507FE7-7217-409C-971F-3CC9162057FAQ33850485-DEF94C24-0B6C-4E8A-B13D-D404B4E8CF22Q34374548-4363AEC5-65C4-429D-8696-86FD744954ABQ35102667-9C03EAFC-84B2-41B4-8D2D-621F8B46B895Q35674339-6838989C-2BC2-4C4B-9A8A-62D1702FCBB1Q35674957-488E8755-E687-4391-9FBE-82E8700FE09DQ36053352-21585E77-934A-4AA3-A4E4-CA774D8E4D29Q36195386-E1473196-57C4-45C7-A779-DAF092235797Q36336239-C4B07974-1ED8-47ED-A498-44B6889E8FCEQ36356575-F807F708-6BAD-4751-B6AE-E75FF14F199BQ36463912-6C7F2227-DE2B-44D3-93E1-3621370D2F4FQ36793535-F861AD55-E3C0-498F-9977-E71B5A5A80F0Q36839285-44BCAE13-5FE1-4779-B474-93EB99ABC0FFQ36874468-38C7D6A0-5145-4120-A274-0B10AC8B2D7BQ37130113-36F1BA1C-74D7-46B7-AA12-D794EA38263AQ37279259-D018EE48-B8B1-44D0-B1BD-758344365C35Q37681743-74FD2D23-3B4D-4292-BCC5-EF0AF8E7E8BDQ37691149-93B44D4A-3426-43AF-9B18-82346A849276Q38194952-73CA757A-9016-4E6C-9EE3-2828553036E7Q38784574-83033C04-AB7B-4B1C-917B-D417A28E4D7EQ38821494-D7CEFDBB-D397-4C91-A516-9F02D9DA263BQ38831074-CF66D96C-9CD5-42BE-B438-7DA6C7FED6F8Q38851505-C9536FAD-A0BE-4756-B226-C56A7E4574BCQ40075679-C66ED887-F50C-48C3-BC80-07DD54F2418EQ40440059-21FB6129-C4B2-48A5-9143-454708DEC501Q40679633-78397F3A-EBA7-40C6-86A5-253162F5B898Q48118322-4A6373E1-2C20-4B9A-B363-0473ABE83030Q48119396-C593D625-B835-475D-9C2B-9DC000FE5343Q51843302-6B9B035F-C52E-4B85-94D1-DEAE15BADBAFQ53400538-4C4FA940-9365-420D-A07A-8CAD43BDE807Q53408150-57F30913-5C91-4BCD-B253-B12C55E2A798Q54338773-EC64BC3B-BE6B-4CAD-862D-9F2BA2AD3E7BQ54964137-884F8FF9-F176-45B3-B15D-39527A90E0EBQ57560981-3685EC4D-454B-49D6-B39D-92FD8929A7DF
P2860
Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mammographic density reduction ...... l patients with breast cancer.
@en
type
label
Mammographic density reduction ...... l patients with breast cancer.
@en
prefLabel
Mammographic density reduction ...... l patients with breast cancer.
@en
P2860
P50
P356
P1476
Mammographic density reduction ...... l patients with breast cancer.
@en
P2093
Louise Eriksson
P2860
P304
P356
10.1200/JCO.2012.44.5015
P407
P577
2013-04-22T00:00:00Z